Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results.
For the past several years we have been working with models of benzene distribution and metabolism, principally in the rat, but more recently in humans. Our biologically related objectives have been primarily to assist our laboratory-based colleagues in their quest for understanding of the mechanisms by which benzene exerts its toxic action. A secondary goal has been to develop or adapt models useful in risk assessment applications. We have also had methodological goals that relate to applications of sensitivity analysis on the one hand, but more fundamentally to the connection between experimental data and model structure and parameterization. This paper presents an overview of our work in these areas.
Spear
R C
RC
School of Public Health, University of California, Berkeley 94720, USA.
Bois
F Y
FY
D000818:Animals; D001554:Benzene / Q000493:pharmacokinetics* / Q000633:toxicity; D006801:Humans; D008297:Male; D008954:Models, Biological; D009010:Monte Carlo Method; D015999:Multivariate Analysis; D051381:Rats; D011916:Rats, Inbred F344; D015203:Reproducibility of Results; D018570:Risk Assessment; D012680:Sensitivity and Specificity
D001554:Benzene